CD229
Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response. Activities are controlled by presence or absence of small cytoplasmic adapter proteins, SH2D1A/SAP and/or SH2D1B/EAT-2. May participate in adhesion reactions between T lymphocytes and accessory cells by homophilic interaction. Promotes T-cell differentiation into a helper T-cell Th17 phenotype leading to increased IL-17 secretion; the costimulatory activity requires SH2D1A. Promotes recruitment of RORC to the IL-17 promoter. May be involved in the maintenance of peripheral cell tolerance by serving as a negative regulator of the immune response. May disable autoantibody responses and inhibit IFN-gamma secretion by CD4(+) T-cells. May negatively regulate the size of thymic innate CD8(+) T-cells and the development of invariant natural killer T (iNKT) cells. Increased surface expression on T-cells of systemic lupus erythematosus (SLE) patients. 4 alternatively spliced human isoforms have been reported. Note: This description may include information from UniProtKB.
|
Protein type: Cell surface; Membrane protein, integral |
Chromosomal Location of human Ortholog: 1q23.3 |
Cellular Component:
external side of plasma membrane; plasma membrane
|
Biological Process:
cell adhesion; innate immune response; positive regulation of interleukin-17 production; T cell activation; T-helper 17 cell lineage commitment
|
Reference #:
Q9HBG7
(UniProtKB)
|
Alt. Names/Synonyms: CD229; Cell surface molecule Ly-9; cell-surface molecule Ly-9; hly9; LY9; Lymphocyte antigen 9; mLY9; Signaling lymphocytic activation molecule 3; SLAM family member 3; SLAMF3; T-lymphocyte surface antigen Ly-9
|
Gene Symbols: LY9
|
Molecular weight:
72,139 Da
|
Basal Isoelectric point:
5.36
Predict pI for various phosphorylation states
|
Protein-Specific Antibodies, siRNAs or Recombinant Proteins from Cell Signaling Technology®
|